Divis Laboratories rises on getting no observations after USFDA inspection

22 Feb 2016 Evaluate

Divis Laboratories is currently trading at Rs 1005.55, up by 11.65 points or 1.17% from its previous closing of Rs. 993.90 on the BSE.

The scrip opened at Rs. 1022.90 and has touched a high and low of Rs. 1029.90 and Rs. 1001.00 respectively. So far 7948 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1241.80 on 21-Aug-2015 and a 52 week low of Rs. 825.00 on 19-Feb-2015.

Last one week high and low of the scrip stood at Rs. 1016.00 and Rs. 931.00 respectively. The current market cap of the company is Rs. 26594.64 crore.

The promoters holding in the company stood at 52.08% while Institutions and Non-Institutions held 33.66% and 14.26% respectively.

Divis Laboratories had a successful inspection by the US-FDA for its Unit-2 at Chippada, Bheemunipatnam near Visakhapatnam during February, 2016 with no observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Divis Lab Share Price

6473.35 2.75 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×